Tandem Diabetes Care, Inc. TNDM
17.34 USD +0.54 (+3.21%)
As ofNov 20, 2026, 2:34 PM EST
16.51 Day range 17.86
12.26 52-week range 29.65
- YTD
- -21.11%
- 1 year
- -11.08%
Revenue & Expenses
Revenue by
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 1.01B | 940.20M | 747.72M | 801.22M | 702.80M | |
| 546.01M | 489.57M | 367.69M | 412.99M | 376.21M | |
| -187.26M | -99.13M | -233.23M | -92.85M | 22.65M | |
| -204.71M | -96.03M | -222.61M | -94.59M | 15.57M | |
| -3.04 | -1.47 | -3.43 | -1.47 | 0.24 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 90.63M | 69.23M | 58.87M | 172.52M | 71.18M | |
| 881.11M | 967.66M | 952.66M | 1.05B | 905.14M | |
| 725.94M | 704.56M | 639.03M | 612.84M | 472.02M | |
| 444.48M | 473.56M | 415.67M | 419.88M | 314.67M | |
| 155.17M | 263.10M | 313.63M | 439.95M | 433.11M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -9.72M | 24.23M | -31.81M | 50.46M | 111.36M | |
| 72.88M | -23.48M | -85.74M | 33.17M | -186.88M | |
| -43.37M | 8.37M | 4.11M | 16.88M | 51.93M | |
| -19.95M | -19.23M | -26.80M | -34.10M | -14.18M | |
| 21.40M | 10.37M | -113.65M | 101.34M | -23.43M |
